|
AU6595100A
(en)
*
|
1999-08-20 |
2001-03-19 |
Takeda Chemical Industries Ltd. |
Percutaneous absorption agents
|
|
KR20030087657A
(ko)
|
2001-03-27 |
2003-11-14 |
더 리전츠 오브 더 유니버시티 오브 캘리포니아 |
체지방 감소 및 지방산 대사 조절을 위한 방법, 화합물 및조성물
|
|
US20050054730A1
(en)
*
|
2001-03-27 |
2005-03-10 |
The Regents Of The University Of California |
Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha
|
|
ATE519485T1
(de)
*
|
2001-03-29 |
2011-08-15 |
Michael Davis |
Akute pharmakologische verstärkung einer psychotherapie mit d-cycloserine
|
|
US9493805B2
(en)
*
|
2001-06-01 |
2016-11-15 |
Colorado State University Research Foundation |
Enzymatic biosensors with enhanced activity retention for detection of organic compounds
|
|
US9493806B2
(en)
|
2001-06-01 |
2016-11-15 |
Colorado State University Research Foundation |
Enzymatic biosensing systems
|
|
US8323956B2
(en)
*
|
2001-06-01 |
2012-12-04 |
Colorado State University Research Foundation |
Distal tip of biosensor transducer comprising enzyme for deamination
|
|
EP1558591B1
(en)
*
|
2002-10-07 |
2014-05-07 |
The Regents of The University of California |
Modulation of anxiety through blockade of anandamide hydrolysis
|
|
US7765162B2
(en)
*
|
2002-10-07 |
2010-07-27 |
Mastercard International Incorporated |
Method and system for conducting off-line and on-line pre-authorized payment transactions
|
|
JP2006516095A
(ja)
*
|
2002-11-14 |
2006-06-22 |
ザ スクリップス リサーチ インスティテュート |
脂肪酸アミドヒドロラーゼ（ｆａａｈ）の結晶形
|
|
JP2007509066A
(ja)
*
|
2003-10-16 |
2007-04-12 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
体脂肪を減らし、食欲を抑制し、脂肪酸代謝を調節するための食物および他の組成物、化合物ならびに方法
|
|
US8086315B2
(en)
|
2004-02-12 |
2011-12-27 |
Asap Medical, Inc. |
Cardiac stimulation apparatus and method for the control of hypertension
|
|
US20060084659A1
(en)
*
|
2004-10-19 |
2006-04-20 |
Michael Davis |
Augmentation of psychotherapy with cannabinoid reuptake inhibitors
|
|
EP1831364A1
(en)
*
|
2004-12-22 |
2007-09-12 |
Warner-Lambert Company LLC |
Compositions and methods for expression and purification of fatty acid amide hydrolase
|
|
US20090068107A1
(en)
*
|
2006-10-02 |
2009-03-12 |
The Scripps Research Institute |
Enzyme regulating ether lipid signaling pathways
|
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
|
GEP20125425B
(en)
*
|
2006-10-18 |
2012-03-26 |
Pfizer Prod Inc |
Biaryl ether urea compounds
|
|
US9796998B2
(en)
|
2007-04-09 |
2017-10-24 |
Colorado State University Research Foundation |
Oxygenase-based biosensing systems for measurement of halogenated alkene concentrations
|
|
CA2702468A1
(en)
|
2007-10-12 |
2009-04-23 |
University Of Connecticut |
Therapeutic applications of fatty acid amide hydrolase inhibitors
|
|
AU2009233711B2
(en)
*
|
2008-04-09 |
2015-02-12 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
|
WO2010118159A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
WO2010118155A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
WO2010124113A1
(en)
|
2009-04-23 |
2010-10-28 |
Infinity Pharmaceuticals, Inc. |
Anti-fatty acid amide hydrolase-2 antibodies and uses thereof
|
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
BR112012019120A2
(pt)
|
2010-02-03 |
2016-06-28 |
Infinity Pharmaceuticais Inc |
forma sólida, composição farmacêutica, método de preparação do composto 1, método de tratamento de uma condição mediada por faah
|
|
TW201206440A
(en)
*
|
2010-04-28 |
2012-02-16 |
Astellas Pharma Inc |
Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
|
|
JP2013147430A
(ja)
*
|
2010-04-28 |
2013-08-01 |
Astellas Pharma Inc |
夜間頻尿の予防又は治療剤
|
|
EP2598477B1
(en)
|
2010-07-28 |
2016-03-02 |
The Regents of The University of California |
Peripherally restricted faah inhibitors
|
|
US10024797B2
(en)
|
2010-11-22 |
2018-07-17 |
Colorado State University Research Foundation |
Biosensing systems for measurement of lactose
|
|
WO2013019982A2
(en)
|
2011-08-02 |
2013-02-07 |
Colorado State University Research Foundation |
Biosensing system with extended lifetime via cofactor recycling
|
|
JP6092870B2
(ja)
|
2011-08-19 |
2017-03-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
メタ置換ビフェニル末梢に限局されたｆａａｈ阻害剤
|
|
US9737562B2
(en)
|
2012-12-11 |
2017-08-22 |
The Mclean Hospital Corporation |
Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders
|
|
US9008769B2
(en)
|
2012-12-21 |
2015-04-14 |
Backbeat Medical, Inc. |
Methods and systems for lowering blood pressure through reduction of ventricle filling
|
|
US9579617B2
(en)
|
2012-12-28 |
2017-02-28 |
Dow Global Technologies Llc |
Aqueous dispersion of fatty amide
|
|
MX372678B
(es)
|
2012-12-28 |
2020-03-25 |
Rohm & Haas |
Adhesivos hidrosolubles.
|
|
US9370662B2
(en)
|
2013-12-19 |
2016-06-21 |
Backbeat Medical, Inc. |
Methods and systems for controlling blood pressure by controlling atrial pressure
|
|
GB201404468D0
(en)
*
|
2014-03-13 |
2014-04-30 |
Givaudan Sa |
Process
|
|
ES2908240T3
(es)
|
2014-04-07 |
2022-04-28 |
Univ California |
Inhibidores de la enzima amida hidrolasa de ácidos grasos (FAAH) con biodisponibilidad oral mejorada y su uso como medicamentos
|
|
US10342982B2
(en)
|
2015-09-11 |
2019-07-09 |
Backbeat Medical, Inc. |
Methods and systems for treating cardiac malfunction
|
|
EP3913068B1
(en)
|
2015-10-12 |
2023-08-02 |
Advanced Cell Diagnostics, Inc. |
In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
|
|
US10485658B2
(en)
|
2016-04-22 |
2019-11-26 |
Backbeat Medical, Inc. |
Methods and systems for controlling blood pressure
|
|
WO2019055541A1
(en)
|
2017-09-12 |
2019-03-21 |
Ginkgo Bioworks, Inc. |
PROTECTIVE ENZYMES
|